Get started
CHARLES RIVER LABCHARLES RIVER LABCHARLES RIVER LAB

CHARLES RIVER LAB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

1CRL chart


Full chart

1CRL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.95 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.60 EUR
Net income (FY)
‪9.95 M‬ EUR
Revenue (FY)
‪3.91 B‬ EUR
Shares float
‪48.54 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
‪20.1 K‬
Change (1Y)
‪−1.7 K‬ −7.80%
Revenue / Employee (1Y)
‪194.64 K‬ EUR
Net income / Employee (1Y)
494.86 EUR

About Charles River Laboratories International, Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
James C. Foster
Website
criver.com
Headquarters
Wilmington
Founded
1947
FIGI
BBG01TNXVW84
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1CRL news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1CRL highest yielding bonds


CRL4900987
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028
Yield to maturity
6.73%
Maturity date
May 1, 2028
CRL5145814
Charles River Laboratories International, Inc. 3.75% 15-MAR-2029
Yield to maturity
6.41%
Maturity date
Mar 15, 2029
CRL5145816
Charles River Laboratories International, Inc. 4.0% 15-MAR-2031
Yield to maturity
6.21%
Maturity date
Mar 15, 2031
CRL4900988
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028
Yield to maturity
—
Maturity date
May 1, 2028

See all 1CRL bonds 


Check out other big names from the same industry as 1CRL.

Frequently Asked Questions


The current price of 1CRL is 126.05 EUR — it has increased by 12.68% in the past 24 hours. Watch CHARLES RIVER LAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange CHARLES RIVER LAB stocks are traded under the ticker 1CRL.
1CRL stock has risen by 13.50% compared to the previous week, the month change is a 18.39% rise, over the last year CHARLES RIVER LAB has showed a 27.22% increase.
We've gathered analysts' opinions on CHARLES RIVER LAB future price: according to them, 1CRL price has a max estimate of 166.20 EUR and a min estimate of 61.88 EUR. Watch 1CRL chart and read a more detailed CHARLES RIVER LAB stock forecast: see what analysts think of CHARLES RIVER LAB and suggest that you do with its stocks.
1CRL reached its all-time high on May 2, 2025 with the price of 105.60 EUR, and its all-time low was 99.10 EUR and was reached on Apr 25, 2025. View more price dynamics on 1CRL chart.
See other stocks reaching their highest and lowest prices.
1CRL stock is 6.94% volatile and has beta coefficient of 0.39. Track CHARLES RIVER LAB stock price on the chart and check out the list of the most volatile stocks — is CHARLES RIVER LAB there?
Today CHARLES RIVER LAB has the market capitalization of ‪5.95 B‬, it has increased by 7.01% over the last week.
Yes, you can track CHARLES RIVER LAB financials in yearly and quarterly reports right on TradingView.
CHARLES RIVER LAB is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1CRL earnings for the last quarter are 2.16 EUR per share, whereas the estimation was 1.92 EUR resulting in a 12.73% surprise. The estimated earnings for the next quarter are 2.18 EUR per share. See more details about CHARLES RIVER LAB earnings.
CHARLES RIVER LAB revenue for the last quarter amounts to ‪909.71 M‬ EUR, despite the estimated figure of ‪870.70 M‬ EUR. In the next quarter, revenue is expected to reach ‪864.52 M‬ EUR.
1CRL net income for the last quarter is ‪23.54 M‬ EUR, while the quarter before that showed ‪−208.36 M‬ EUR of net income which accounts for 111.30% change. Track more CHARLES RIVER LAB financial stats to get the full picture.
No, 1CRL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 8, 2025, the company has ‪20.1 K‬ employees. See our rating of the largest employees — is CHARLES RIVER LAB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHARLES RIVER LAB EBITDA is ‪842.66 M‬ EUR, and current EBITDA margin is 22.93%. See more stats in CHARLES RIVER LAB financial statements.
Like other stocks, 1CRL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHARLES RIVER LAB stock right from TradingView charts — choose your broker and connect to your account.